Lupin Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PIRFENIDONE, with a corresponding US DMF Number 30351.
Remarkably, this DMF maintains an Active status since its submission on April 13, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 31, 2017, and payment made on September 22, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II